Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis

Biochemical and Biophysical Research Communications

Volumn 428, Issue 4, 2012, Pages 487-493

  Szkudlarek Mikho, Maria ^a   Saunders, Rudel A ^a   Yap, Sook Fan ^b   Ngeow, Yun Fong ^c   Chin, Khew Voon ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Adipogenesis; Ionophoric antibiotic; Obesity; Polyether antibiotic; Salinomycin

Indexed keywords

MONENSIN; NARASIN; SALINOMYCIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADIPOGENESIS; ANIMALS; ANTI-BACTERIAL AGENTS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; IONOPHORES; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PYRANS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

ANIMALIA;

EID: 84870331378     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.080     Document Type: Article

References (34)

1. Sapkota A.R., Lefferts L.Y., McKenzie S., Walker P. What do we feed to food-production animals? a review of animal feed ingredients and their potential impacts on human health. Environ. Health Perspect. 2007, 115:663-670.
2. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
3. Huczynski A. Salinomycin: a new cancer drug candidate. Chem. Biol. Drug Des. 2012, 79:235-238.
4. Shao Q., Chin K.V. Survey of American food trends and the growing obesity epidemic. Nutr. Res. Pract. 2011, 5:253-259.
5. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2009.
6. Swinburn B., Sacks G., Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am. J. Clin. Nutr. 2009, 90:1453-1456.
7. E. Maury, S.M. Brichard, Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome, Mol. Cell. Endocrinol. 314 (2010) 1-16.
8. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
9. Wolins N.E., Quaynor B.K., Skinner J.R., Tzekov A., Park C., Choi K., Bickel P.E. OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis. J. Lipid Res. 2006, 47:450-460.
10. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20:107-114.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
12. Cvijic M.E., Chin K.V. Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin. Int. J. Cancer 1997, 72:345-350.
13. Kablan A., Saunders R.A., Szkudlarek-Mikho M., Chin A.J., Bosio R.M., Fujii K., Shapiro J., Chin K.V. Prieurianin causes weight loss in diet-induced obese mice and inhibits adipogenesis in cultured preadipocytes. J. Diabetes Metab. 2010, 1.
14. Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., Reddy J.K. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci. USA 1995, 92:7921-7925.
15. Schepsky A., Bruser K., Gunnarsson G.J., Goodall J., Hallsson J.H., Goding C.R., Steingrimsson E., Hecht A. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol. Cell Biol. 2006, 26:8914-8927.
16. Riddell F.G. Structure, conformation, and mechanism in the membrane transport of alkali metal ions by ionophoric antibiotics. Chirality 2002, 14:121-125.
17. Fowler S.D., Greenspan P. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J. Histochem. Cytochem. 1985, 33:833-836.
18. Simons P.J., van den Pangaart P.S., van Roomen C.P., Aerts J.M., Boon L. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers. Cytokine 2005, 32:94-103.
19. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 1995, 184:39-51.
20. Sharma A.M., Staels B. Review: peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 2007, 92:386-395.
21. Marcelin G., Chua S. Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity. Curr. Opin. Pharmacol. 2010, 10:588-593.
22. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316:129-139.
23. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
24. Caldeira C., Neves W.S., Cury P.M., Serrano P., Baptista M.A., Burdmann E.A. Rhabdomyolysis, acute renal failure, and death after monensin ingestion. Am. J. Kidney Dis. 2001, 38:1108-1112.
25. Kouyoumdjian J.A., Morita M.P., Sato A.K., Pissolatti A.F. Fatal rhabdomyolysis after acute sodium monensin (Rumensin) toxicity: case report. Arq. Neuropsiquiatr. 2001, 59:596-598.
26. Sharma N., Bhalla A., Varma S., Jain S., Singh S. Toxicity of maduramicin. Emerg. Med. J. 2005, 22:880-882.
27. Story P., Doube A. A case of human poisoning by salinomycin, an agricultural antibiotic. NZ Med. J. 2004, 117:U799.
28. Mortier L., Huet A.C., Charlier C., Daeseleire E., Delahaut P., Van Peteghem C. Incidence of residues of nine anticoccidials in eggs. Food Addit. Contam. 2005, 22:1120-1125.
29. Henri J., Maurice R., Postollec G., Dubreil-Cheneau E., Roudaut B., Laurentie M., Sanders P. Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys. J. Vet. Pharmacol. Ther. 2012, 35:73-81.
30. Fuchs D., Heinold A., Opelz G., Daniel V., Naujokat C. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem. Biophys. Res. Commun. 2009, 390:743-749.
31. Jaitovich A.A., Bertorello A.M. Na+, K+ -ATPase: an indispensable ion pumping-signaling mechanism across mammalian cell membranes. Semin. Nephrol. 2006, 26:386-392.
32. Kawakami K., Onaka T., Iwase M., Homma I., Ikeda K. Hyperphagia and obesity in Na, K-ATPase alpha2 subunit-defective mice. Obes. Res. 2005, 13:1661-1671.
33. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
34. Lu D., Choi M.Y., Yu J., Castro J.E., Kipps T.J., Carson D.A. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl. Acad. Sci. USA 2011, 108:13253-13257.